NCT05545202View on ClinicalTrials.gov

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

February 15, 2025

Study Completion Date

February 15, 2025

Conditions
Malignant LymphomaMultiple Myeloma
Interventions
OTHER

Pentaisomaltose

Each subject will receive 1 or 2 bags with cryopreserved cells according to randomization group.

Sponsors

Lead Sponsor

Pharmacosmos A/S
All Listed Sponsors
lead

Pharmacosmos A/S

INDUSTRY